Insider · CIK 0001385112

Aviezer David

Reports to the SEC for 1 company · CARMIEL, L3

sec.gov

Transactions

Companies

Filings

CIK

0001385112

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-07-16	PLXProtalix BioTherapeutics, Inc.A Award	Director, President & CEO	AAward	+418K sh	—	—	418,000
2012-05-02	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+326K sh	$0.12	+$39.2K	326,267
2012-05-02	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+124K sh	$0.97	+$120K	450,000
2012-05-02	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−450K sh	$7.13	−$3.21M	0
2012-05-02	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−326K sh	—	—	0
2012-05-02	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−124K sh	—	—	853,563
2010-02-25	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President & CEO	AAward	+250K sh	—	—	250,000
2009-10-21	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−247K sh	—	—	326,267
2009-10-21	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−34.2K sh	$9.36	−$320K	0
2009-10-21	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+247K sh	$0.12	+$29.7K	0
2009-10-21	PLXProtalix BioTherapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−3,253 sh	$9.13	−$29.7K	0
2009-10-20	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−60K sh	$9.45	−$567K	0
2009-10-19	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−150K sh	$9.43	−$1.41M	0
2009-05-12	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−55.9K sh	$3.41	−$191K	0
2009-05-12	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−104K sh	—	—	573,757
2009-05-12	PLXProtalix BioTherapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−3,571 sh	$3.48	−$12.4K	0
2009-05-12	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+104K sh	$0.12	+$12.4K	0
2009-05-11	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−38.9K sh	$3.41	−$133K	0
2009-05-08	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−5,200 sh	$3.40	−$17.7K	0
2009-05-06	PLXProtalix BioTherapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−3,061 sh	$3.06	−$9,366.66	0
2009-05-06	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−20K sh	$3.01	−$60.2K	0
2009-05-06	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+78.1K sh	$0.12	+$9,367.32	0
2009-05-06	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−78.1K sh	—	—	677,328
2009-05-05	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−21.6K sh	$3.07	−$66.3K	0
2009-05-04	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−33.4K sh	$3.01	−$101K	0
2009-04-20	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−33.3K sh	$2.51	−$83.6K	0
2009-04-20	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−52.5K sh	—	—	755,389
2009-04-20	PLXProtalix BioTherapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−2,469 sh	$2.55	−$6,295.95	0
2009-04-20	PLXProtalix BioTherapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+52.5K sh	$0.12	+$6,296.28	0
2009-04-17	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−10K sh	$2.56	−$25.6K	0
2009-04-16	PLXProtalix BioTherapeutics, Inc.S Sale	Director, President & CEO	SSale	−6,700 sh	$2.50	−$16.8K	0
2009-02-25	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Jul 184
Aviezer David0001144204-12-039992
SEC(opens sec.gov)
May 44
Aviezer David0001144204-12-026347
SEC(opens sec.gov)
Feb 264
Aviezer David0001209191-10-012574
SEC(opens sec.gov)
Oct 214
Protalix BioTherapeutics, Inc.0001209191-09-049447
SEC(opens sec.gov)
May 124
Aviezer David0001209191-09-026022
SEC(opens sec.gov)
May 64
Aviezer David0001209191-09-024860
SEC(opens sec.gov)

Companies

Protalix BioTherapeutics, Inc.Director, President & CEOPLX

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100